Skip to main content
Livermore
Livermore
ZHEN

Verrica Pharmaceuticals Inc.

VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001660334

In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Verrica Pharmaceuticals Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
34
−25 vs. Q2 2025
Shares held
2.47M
−19.4K (−0.8%) vs. Q2 2025Converted for a 1-for-10 split
Total value
$10.6M
−$2.86M (−21.3%) vs. Q2 2025
New holders
6
11 more added
Sold out
31
15 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRCA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 34 institutions
Q1 2021: 51 institutionsQ2 2021: 53 institutionsQ3 2021: 49 institutionsQ4 2021: 45 institutionsQ1 2022: 51 institutionsQ2 2022: 57 institutionsQ3 2022: 49 institutionsQ4 2022: 50 institutionsQ1 2023: 60 institutionsQ2 2023: 63 institutionsQ3 2023: 67 institutionsQ4 2023: 64 institutionsQ1 2024: 62 institutionsQ2 2024: 74 institutionsQ3 2024: 79 institutionsQ4 2024: 81 institutionsQ1 2025: 75 institutionsQ2 2025: 59 institutionsQ3 2025: 34 institutionsQ4 2025: 50 institutionsQ1 2026: 39 institutionsQ2 2026: 43 institutions
Value heldQ3 2025: $10.6M
Q1 2021: $150.4MQ2 2021: $112.3MQ3 2021: $114.6MQ4 2021: $82.0MQ1 2022: $72.1MQ2 2022: $21.8MQ3 2022: $29.9MQ4 2022: $29.8MQ1 2023: $84.2MQ2 2023: $84.2MQ3 2023: $58.5MQ4 2023: $131.8MQ1 2024: $105.1MQ2 2024: $135.9MQ3 2024: $21.6MQ4 2024: $21.0MQ1 2025: $13.0MQ2 2025: $13.4MQ3 2025: $10.6MQ4 2025: $43.2MQ1 2026: $25.3MQ2 2026: $28.5M
Institutions holding VRCA and their total value by quarter
QuarterHoldersValue
Q2 202643$28.5M
Q1 202639$25.3M
Q4 202550$43.2M
Q3 202534$10.6M
Q2 202559$13.4M
Q1 202575$13.0M
Q4 202481$21.0M
Q3 202479$21.6M
Q2 202474$135.9M
Q1 202462$105.1M
Q4 202364$131.8M
Q3 202367$58.5M
Q2 202363$84.2M
Q1 202360$84.2M
Q4 202250$29.8M
Q3 202249$29.9M
Q2 202257$21.8M
Q1 202251$72.1M
Q4 202145$82.0M
Q3 202149$114.6M
Q2 202153$112.3M
Q1 202151$150.4M

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Verrica Pharmaceuticals Inc.; share changes are against Q2 2025.

Institutions holding VRCA in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Caligan Partners LP923,910$3.98M0.55%00.0%UnchangedConverted for a 1-for-10 split
Armistice Capital, LLC639,193$2.75M0.09%−248,941−28.0%ReducedConverted for a 1-for-10 split
Boothbay Fund Management, LLC280,734$1.21M0.03%+280,734New
Vanguard Group Inc225,210$970.7K0.00%+8,379+3.9%AddedConverted for a 1-for-10 split
Millennium Management LLC71,990$310.3K0.00%−18,718−20.6%ReducedConverted for a 1-for-10 split
Geode Capital Management, LLC67,659$291.7K0.00%+3,043+4.7%AddedConverted for a 1-for-10 split
Sovran Advisors, LLC73,805$260.5K0.02%−1,234−1.6%ReducedConverted for a 1-for-10 split
UBS Group AG41,632$179.4K0.00%+34,359+472.4%AddedConverted for a 1-for-10 split
Renaissance Technologies LLC29,191$125.8K0.00%+20,471+234.8%AddedConverted for a 1-for-10 split
Mariner, LLC24,550$105.8K0.00%−1,980−7.5%ReducedConverted for a 1-for-10 split
Morgan Stanley21,688$93.5K0.00%+19,061+725.7%AddedConverted for a 1-for-10 split
State Street Corp20,581$88.7K0.00%+11,399+124.2%AddedConverted for a 1-for-10 split
Northern Trust Corp20,031$86.3K0.00%−709−3.4%ReducedConverted for a 1-for-10 split
Bridgeway Capital Management, LLC12,000$51.7K0.00%+12,000New
BlackRock, Inc.6,148$26.5K0.00%+501+8.9%AddedConverted for a 1-for-10 split
FMR LLC3,337$14.4K0.00%−577−14.7%ReducedConverted for a 1-for-10 split
Citigroup Inc2,065$8.90K0.00%+1,725+506.6%AddedConverted for a 1-for-10 split
Tower Research Capital LLC (TRC)1,543$6.65K0.00%−1,146−42.6%ReducedConverted for a 1-for-10 split
Capital Analysts, LLC1,500$6.00K0.00%−630−29.6%ReducedConverted for a 1-for-10 split
Royal Bank of Canada1,209$5.00K0.00%+704+139.3%AddedConverted for a 1-for-10 split
Salomon & Ludwin, LLC290$1.35K0.00%00.0%UnchangedConverted for a 1-for-10 split
New England Capital Financial Advisors LLC200$8620.00%+200New
Nisa Investment Advisors, LLC142$6120.00%−1−0.8%ReducedConverted for a 1-for-10 split
BNP Paribas Arbitrage, SA124$5340.00%−14−10.1%ReducedConverted for a 1-for-10 split
The PNC Financial Services Group, Inc.102$4390.00%−1−1.1%ReducedConverted for a 1-for-10 split
Bank of America Corp72$3100.00%−342−82.6%ReducedConverted for a 1-for-10 split
Advisor Group Holdings, Inc.568$3010.00%+511+900.0%AddedConverted for a 1-for-10 split
Optiver Holding B.V.31$1340.00%+31New
SRS Capital Advisors, Inc.9$380.00%+9New
Group One Trading, L.P.3$130.00%+1+25.0%AddedConverted for a 1-for-10 split
MAI Capital Management2$90.00%+2New
Barclays PLC1$40.00%−1−37.5%ReducedConverted for a 1-for-10 split
CWM, LLC56$00.00%−306−84.5%ReducedConverted for a 1-for-10 split
Covestor Ltd54$00.00%−1−0.9%ReducedConverted for a 1-for-10 split
Y-Intercept (Hong Kong) Ltd0$00.00%−18,696−100.0%Sold outConverted for a 1-for-10 split
Goldman Sachs Group Inc0$00.00%−17,528−100.0%Sold outConverted for a 1-for-10 split
BML Capital Management, LLC0$00.00%−17,465−100.0%Sold outConverted for a 1-for-10 split
Marshall Wace, LLP0$00.00%−12,395−100.0%Sold outConverted for a 1-for-10 split
Two Sigma Investments, LP0$00.00%−8,729−100.0%Sold outConverted for a 1-for-10 split
Steel Peak Wealth Management LLC0$00.00%−7,600−100.0%Sold outConverted for a 1-for-10 split
Beck Mack & Oliver LLC0$00.00%−7,000−100.0%Sold outConverted for a 1-for-10 split
Citadel Advisors LLC0$00.00%−6,866−100.0%Sold outConverted for a 1-for-10 split
Susquehanna International Group, LLP0$00.00%−6,659−100.0%Sold outConverted for a 1-for-10 split
Miracle Mile Advisors, LLC0$00.00%−5,977−100.0%Sold outConverted for a 1-for-10 split
Qube Research & Technologies Ltd0$00.00%−5,296−100.0%Sold outConverted for a 1-for-10 split
AQR Capital Management LLC0$00.00%−5,027−100.0%Sold outConverted for a 1-for-10 split
Jane Street Group, LLC0$00.00%−3,833−100.0%Sold outConverted for a 1-for-10 split
SPC Financial, Inc.0$00.00%−3,000−100.0%Sold outConverted for a 1-for-10 split
Dynamic Technology Lab Private Ltd0$00.00%−2,030−100.0%Sold outConverted for a 1-for-10 split
Creative Planning0$00.00%−1,908−100.0%Sold outConverted for a 1-for-10 split
Wealth Enhancement Advisory Services, LLC0$00.00%−1,157−100.0%Sold outConverted for a 1-for-10 split
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−1,372−100.0%Sold outConverted for a 1-for-10 split
Cambridge Investment Research Advisors, Inc.0$00.00%−1,150−100.0%Sold outConverted for a 1-for-10 split
XTX Topco Ltd0$00.00%−1,106−100.0%Sold outConverted for a 1-for-10 split
Key Financial Inc0$00.00%−942−100.0%Sold outConverted for a 1-for-10 split
Raymond James Financial Inc0$00.00%−840−100.0%Sold outConverted for a 1-for-10 split
Legacy Trust0$00.00%−650−100.0%Sold outConverted for a 1-for-10 split
Wells Fargo & Company0$00.00%−493−100.0%Sold outConverted for a 1-for-10 split
Cubist Systematic Strategies, LLC0$00.00%−196−100.0%Sold outConverted for a 1-for-10 split
Ameritas Advisory Services, LLC0$00.00%−30−100.0%Sold outConverted for a 1-for-10 split
Jones Financial Companies LLLP0$00.00%−7−100.0%Sold outConverted for a 1-for-10 split
EverSource Wealth Advisors, LLC0$00.00%−5−100.0%Sold outConverted for a 1-for-10 split
Essential Partners LLC0$00.00%−2−100.0%Sold outConverted for a 1-for-10 split
IFP Advisors, Inc0$00.00%−1−100.0%Sold outConverted for a 1-for-10 split
SBI Securities Co., Ltd.0$00.00%−0−100.0%Sold outConverted for a 1-for-10 split